CART-19 Cells for R/R B-cell Lymphoma

Clinical trial NCT03391726 · UNKNOWN

Trial details

NCT number: NCT03391726
Sponsor: Fujian Medical University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Relapsed or Refractory B-cell Lymphoma

Start date: 2016-01-01
Primary completion: 2019-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.